Oncoscience

Volume 2: Issue 4

pp317-442

Issue 4

About the Cover

The cover for the issue of Oncoscience features Figure 6 (“The DAXX co-repressor is directly recruited to active regulatory elements genome-wide to regulate autophagy programs in a model of human prostate cancer”) from Puto et al.

Editorials

Oncogene-induced NAD+ depletion in tumorigenesis

https://doi.org/10.18632/oncoscience.154

Krishna S. Tummala, Nabil  Djouder

p 318-319

PDF

Reviews

AID/APOBEC deaminases and cancer

https://doi.org/10.18632/oncoscience.155

Stefan  Rebhandl, Michael  Huemer, Richard  Greil, Roland  Geisberger

p 320-333

Abstract |  PDF |  Full Text

Research Papers

MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1

https://doi.org/10.18632/oncoscience.137

Kedar  Yogi, Epari  Sridhar, Naina  Goel, Rakesh  Jalali, Atul  Goel, Ali Asgar Moiyadi, Rahul  Thorat, Pooja  Panwalkar, Atul  Khire, Archya  Daspgupta, Prakash  Shetty, Neelam Vishwanath Shirsat

p 334-348

Abstract |  PDF |  Full Text |  Supplementary Materials

Induction of functional Brm protein from Brm knockout mice

https://doi.org/10.18632/oncoscience.153

Kenneth  Thompson, Stefanie B. Marquez, Li  Lu, David  Reisman

p 349-361

Abstract |  PDF |  Full Text |  Supplementary Materials

The DAXX co-repressor is directly recruited to active regulatory elements genome-wide to regulate autophagy programs in a model of human prostate cancer

https://doi.org/10.18632/oncoscience.152

Lorena A. Puto, Christopher  Benner, Tony  Hunter

p 362-372

Abstract |  PDF |  Full Text

Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer

https://doi.org/10.18632/oncoscience.150

Isabella Monia Montagner, Anna  Merlo, Debora  Carpanese, Gaia  Zuccolotto, Davide  Renier, Monica  Campisi, Gianfranco  Pasut, Paola  Zanovello, Antonio  Rosato

p 373-381

Abstract |  PDF |  Full Text |  Supplementary Materials

mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein

https://doi.org/10.18632/oncoscience.148

Tommasina  Guglielmelli, Emilia  Giugliano, Vanessa  Brunetto, Ida  Rapa, Susanna  Cappia, Jessica  Giorcelli, Sokol  Rrodhe, Mauro  Papotti, Giuseppe  Saglio

p 382-394

Abstract |  PDF |  Full Text

Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.

https://doi.org/10.18632/oncoscience.147

Consuelo  Amantini, Maria Beatrice Morelli, Matteo  Santoni, Alessandra  Soriani, Claudio  Cardinali, Valerio  Farfariello, Anna Maria  Eleuteri, Laura  Bonfili, Matteo  Mozzicafreddo, Massimo  Nabissi, Stefano  Cascinu, Giorgio  Santoni

p 395-409

Abstract |  PDF |  Full Text |  Supplementary Materials

Epigenetic silencing of S100A2 in bladder and head and neck cancers

https://doi.org/10.18632/oncoscience.140

Juna  Lee, Piotr T. Wysocki, Ozlem  Topaloglu, Leonel  Maldonado, Mariana  Brait, Shahnaz  Begum, David  Moon, Myoung Sook Kim, Joseph A. Califano, David  Sidransky, Mohammad O. Hoque, Chulso  Moon

p 410-418

Abstract |  PDF |  Full Text |  Supplementary Materials

FS-93, an Hsp90 inhibitor, induces G2/M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cells

https://doi.org/10.18632/oncoscience.156

Liping  Zhang, Aijun  Shen, Lu  Wang, Hongchun  Liu, Danqi  Chen, Bing  Xiong, Jinkang  Shen, Meiyu  Geng

p 419-427

Abstract |  PDF |  Full Text

Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues

https://doi.org/10.18632/oncoscience.157

David Z. Kochan, Yaroslav  Ilnytsky, Andrey  Golubov, Scott H. Deibel, Robert J. McDonald, Olga  Kovalchuk

p 428-442

Abstract |  PDF |  Full Text |  Supplementary Materials

Erratum

Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question

https://doi.org/10.18632/oncoscience.158

Khalid O. Alfarouk, Vivek  Subbiah, Daniel  Verduzco, Cyril  Rauch, Abdel Khalig Muddathir, Adil H. H. Bashir, Gamal O. Elhassan, Muntaser E. Ibrahim, Julian David  Polo Orozco, Rosa Angela  Cardone, Stephan J. Reshkin, Salvador  Harguindey

p 317-317

PDF